Company / Financials
VOLITIONRX LTD Financials
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.2M
FY2025 · +59.1% YoY
Net Income
-$27.0M
FY2025 · +24.4% YoY
Profit Margin
-2186.3%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$6.9M
FY2025
Total Debt
$5.8M
-0.17x debt/equity
Equity
-$34.2M
FY2025
ROA
-390.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.2M+59.1% YoYNet Income HistoryProfit after all expenses and taxes-$27.0M+24.4% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$27.0M+24.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$8.5M-18.1% YoYR&D Expense HistoryResearch and development spending$14.4M-26.3% YoYInterest Expense HistoryCost of borrowing and debt obligations-EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-Shares Outstanding HistoryWeighted average diluted shares outstanding96.1M+17.3% YoYTotal Assets HistoryTotal value of all assets owned$6.9M-26.6% YoYTotal Debt HistoryTotal outstanding debt obligations$5.8M+47.2% YoY